PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis

PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis ...

Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025

Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with ...
Health.com

How To Exercise While Taking GLP-1 Medications

Exercise can help improve insulin sensitivity and glucose uptake in muscle cells. Combining GLP-1s with exercise enhances weight loss and cardiovascular health. Endurance and strength training help ...
BMJ Open

Non-pharmacological and psychosocial interventions for comorbid hypertension and depression: a scoping review

Objectives Hypertension and depression frequently co-occur, complicating patient management and worsening outcomes. This scoping review aims to systematically map non-pharmacological interventions for ...